跳至主要内容
临床试验/NCT04652050
NCT04652050撤回不适用

Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation

Hong Nguyen1 个研究点 分布在 1 个国家开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
PK Sampling-measure amount of drug in system

研究概览

简要总结

This is a single-center, observational study of Tolsura PK sampling in lung transplant recipients

详细描述

Patients who are receiving Tolsura as part of their clinical care will be asked to enroll and EMR data and excess biological samples will be collected

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age and older
  • hospitalized at UPMC
  • placed on Tolsura prophylactically by clinical team
  • patients who have had or will have a lung transplant.

排除标准

  • redo lung transplant
  • recipient with dual liver-lung transplant
  • patients with previous history of SOT
  • including other organ transplantation
  • patients with known pre-transplant colonization with moulds resistant to azoles
  • patients with intra-transplant positive cultures for moulds in either transplant recipient or his/her donor
  • patients with a history of hypersensitivity reaction to an azole agent
  • patients who are kept NPO (nothing by mouth, including meds)
  • recipients or donor with HepC PCR positive

研究组 & 干预措施

lung transplants

Lung transplants on Tolsura for infection

干预措施: Tolsura (Drug)

结局指标

主要结局

PK Sampling-measure amount of drug in system

时间窗: one day PK sampling

blood samples around a dosing of Tolsura to determine maximum plasma concentration

次要结局

  • rates of infection post treatment with Tolsura(6 months)

研究者

发起方
Hong Nguyen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hong Nguyen

Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验